CZCiting Zhang

Citing Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Citing Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Biao Zheng

    Department of Thyroid and Parathyroid Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China

    1 shared publication
  • Bo Liang

    Department of General Surgery & Institute of Precision Diagnosis and Treatment of Gastrointestinal Tumors

    1 shared publication
  • Jianhua Qu

    Department of Hepatobiliary Surgery, Peking University Shenzhen Hospital, Shenzhen, China

    1 shared publication
  • Jikui Liu

    Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen, China

    1 shared publication
  • Peng Gong

    Department of General Surgery & Carson International Cancer Research Center, Shenzhen University General Hospital/Shenzhen University Clinical Medical Academy, Shenzhen, Guangdong 518055, China

    1 shared publication
  • Xuefei Li

    Experimental Research Center, Dermatology Hospital, Southern Medical University, Guangzhou 510091, China

    1 shared publication

Latest Publications

  • Open Access

    Characterization of a Tumor-Microenvironment-Relevant Gene Set Based on Tumor Severity in Colon Cancer and Evaluation of Its Potential for Dihydroartemisinin Targeting

    by Bo Liang, Biao Zheng, Yan Zhou, Zheng-Quan Lai, Citing Zhang, Zilong Yan, Zhangfu Li, Xuefei Li, Peng Gong, Jianhua Qu, et al.

    Colon cancer (COAD) is a leading cause of cancer mortality in the world. Most patients with COAD die as a result of cancer cell metastasis. However, the mechanisms underlying the metastatic phenotype of COAD remain unclear. Instead, particular features of the tumor microenvironment (TME) could predict adverse outcomes including metastasis in patients with COAD, and the role of TME in governing COAD progression is undeniable. Therefore, exploring the role of TME in COAD may help us better understand the molecular mechanisms behind COAD progression which may improve clinical outcomes and quality of patients. Here, we identified a Specific TME Regulatory Network including AEBP1, BGN, POST, and FAP (STMERN) that is highly involved in clinical outcomes of patients with COAD. Comprehensive in silico analysis of our study revealed that the STMERN is highly correlated with the severity of COAD. Meanwhile, our results reveal that the STMERN might be associated with immune infiltration in COAD. Importantly, we show that dihydroartemisinin (DHA) potentially interacts with the STMERN. We suggest that DHA might contribute to immune infiltration through regulating the STMERN in COAD. Taken together, our data provide a set of biomarkers of progression and poor prognosis in COAD. These findings could have potential prognostic and therapeutic implications in the progression of COAD.